Economic Evaluation of Ramucirumab as Second-Line Chemotherapy for Previously Treated Advanced Gastric or Gastro-Oesophageal Junction Adenocarcinoma in China
May 1, 2018, 00:00
10.1016/j.jval.2018.04.216
https://www.valueinhealthjournal.com/article/S1098-3015(18)30516-3/fulltext
Title :
Economic Evaluation of Ramucirumab as Second-Line Chemotherapy for Previously Treated Advanced Gastric or Gastro-Oesophageal Junction Adenocarcinoma in China
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)30516-3&doi=10.1016/j.jval.2018.04.216
First page :
Section Title :
Open access? :
No
Section Order :
1062